These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18167451)

  • 21. Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.
    Lee JH; Lee IH; Choe YJ; Kang S; Kim HY; Gai WP; Hahn JS; Paik SR
    Biochem J; 2009 Mar; 418(2):311-23. PubMed ID: 19007333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
    Kim YS; Lim D; Kim JY; Kang SJ; Kim YH; Im H
    Biochem Biophys Res Commun; 2009 Oct; 387(4):682-7. PubMed ID: 19622344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary structural formation of alpha-synuclein amyloids as revealed by g-factor of solid-state circular dichroism.
    Lin XJ; Zhang F; Xie YY; Bao WJ; He JH; Hu HY
    Biopolymers; 2006 Oct; 83(3):226-32. PubMed ID: 16752390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases.
    Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y
    J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of short peptide fragments from alpha-synuclein fibril core identifies a residue important for fibril nucleation: a possible implication for diagnostic applications.
    Yagi H; Takeuchi H; Ogawa S; Ito N; Sakane I; Hongo K; Mizobata T; Goto Y; Kawata Y
    Biochim Biophys Acta; 2010 Oct; 1804(10):2077-87. PubMed ID: 20637318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of the aggregation of an amyloidogenic alpha-synuclein peptide fragment.
    Madine J; Doig AJ; Kitmitto A; Middleton DA
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1113-5. PubMed ID: 16246058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrillogenic and non-fibrillogenic ensembles of SDS-bound human alpha-synuclein.
    Ahmad MF; Ramakrishna T; Raman B; Rao ChM
    J Mol Biol; 2006 Dec; 364(5):1061-72. PubMed ID: 17054982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA induces folding in alpha-synuclein: understanding the mechanism using chaperone property of osmolytes.
    Hegde ML; Rao KS
    Arch Biochem Biophys; 2007 Aug; 464(1):57-69. PubMed ID: 17537399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tilted properties of the 67-78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity.
    Crowet JM; Lins L; Dupiereux I; Elmoualija B; Lorin A; Charloteaux B; Stroobant V; Heinen E; Brasseur R
    Proteins; 2007 Sep; 68(4):936-47. PubMed ID: 17554782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
    Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
    J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.
    Bharathi ; Indi SS; Rao KS
    Neurosci Lett; 2007 Sep; 424(2):78-82. PubMed ID: 17714865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-synuclein multistate folding thermodynamics: implications for protein misfolding and aggregation.
    Ferreon AC; Deniz AA
    Biochemistry; 2007 Apr; 46(15):4499-509. PubMed ID: 17378587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
    Rekas A; Ahn KJ; Kim J; Carver JA
    Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
    Kong B; Chae Y; Lee K
    Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid hydrogel derived from curly protein fibrils of alpha-synuclein.
    Bhak G; Lee S; Park JW; Cho S; Paik SR
    Biomaterials; 2010 Aug; 31(23):5986-95. PubMed ID: 20471079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
    Ghee M; Melki R; Michot N; Mallet J
    FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence determinants regulating fibrillation of human alpha-synuclein.
    Koo HJ; Lee HJ; Im H
    Biochem Biophys Res Commun; 2008 Apr; 368(3):772-8. PubMed ID: 18261982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural properties of pore-forming oligomers of alpha-synuclein.
    Kim HY; Cho MK; Kumar A; Maier E; Siebenhaar C; Becker S; Fernandez CO; Lashuel HA; Benz R; Lange A; Zweckstetter M
    J Am Chem Soc; 2009 Dec; 131(47):17482-9. PubMed ID: 19888725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
    Schnack C; Danzer KM; Hengerer B; Gillardon F
    Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.